The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease

被引:17
|
作者
Zhao, Shu-Wu [1 ]
Wang, Yu-Ping [2 ]
Xu, Lin-Dong [1 ]
Gang, Wei [1 ]
机构
[1] Dagang Hosp, Binhai New Area, Dept Cardiol, 1200 Nanhuan Rd, Tianjin 300270, Peoples R China
[2] Haibin Peoples Hosp Tianjin City, Dept Cardiol, Tianjin 300280, Peoples R China
关键词
Thrombus elasticity; coronary intervention; antiplatelet therapy; RESISTANCE; CLOPIDOGREL; ASPIRIN;
D O I
10.21037/jtd.2016.12.77
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: This study aims to explore the application value of thromboelastogram (TEG) in antiplatelet therapy in coronary artery intervention. Methods: A retrospective analysis of 90 cases of coronary interventional treatment was conducted in our hospital from January 2010 to January 2012. Cases were divided into three groups, according to the kind of coronary heart disease: angina pectoris (AP) group (30 cases), unstable angina pectoris (UAP) group (30 cases) and acute myocardial infarction (AMI) group (30 cases). TEG changes in patients between the three groups were analyzed. Results: The differences in international normalized ratio (INR) and activated partial thromboplastin time (APTT) indexes among the three groups of patients were statistically significant (P<0.05), but these indexes significantly decreased in the AMI group. Furthermore, D-D, Fgb, Angle and MA indexes significantly increased in the UAP and AMI groups, compared with the AP group; while TEG regular parameter K and R values were markedly reduced. Coagulation graphics were higher in the UAP and AMI groups than in the AP group (chi(2)=4.261, 3.908; P<0.05), suggesting that the difference was statistically significant. In 11 cases of ischemic events, arachidonic acid (AA)-induced platelet inhibition rate was 63.63%, while adenosine diphosphate (ADP)-induced platelet inhibition rate was 36.37% (chi(2)=5.026; P<0.05); suggesting that ADP-induced platelet inhibition rate was markedly reduced. This is the main risk of ischemic events within three months after percutaneous coronary intervention. Conclusions: The detection of indexes of antiplatelet therapy in coronary artery intervention is helpful for antiplatelet medication, thus can effectively reduce the incidence of ischemic events.
引用
收藏
页码:3515 / 3520
页数:6
相关论文
共 50 条
  • [1] Antiplatelet Therapy in Coronary Heart Disease Prevention
    Kolandaivelu, Kumaran
    Bhatt, Deepak L.
    [J]. CARDIOLOGY CLINICS, 2011, 29 (01) : 71 - +
  • [2] Antiplatelet Therapy and Anticoagulation in Patients with coronary Heart Disease
    Liedtke, Jan-Patrick
    Ahrens, Ingo
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (16) : 1041 - 1050
  • [3] Antiplatelet Therapy in Coronary Heart Disease. Some Problems and Achivements
    Gratsiansky, N. A.
    [J]. KARDIOLOGIYA, 2010, 50 (06) : 4 - 21
  • [4] What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?
    Otieno, Beryl
    Ibecheozor, Chukwuka
    Williams, Marlene S. S.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (07) : 343 - 350
  • [5] What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?
    Beryl Otieno
    Chukwuka Ibecheozor
    Marlene S. Williams
    [J]. Current Atherosclerosis Reports, 2023, 25 : 343 - 350
  • [6] Antiplatelet treatment for coronary heart disease
    Clappers, N.
    Brouwer, M. A.
    Verheugt, F. W. A.
    [J]. HEART, 2007, 93 (02) : 258 - 265
  • [7] Oral Antiplatelet Therapy in Coronary Disease
    Goncalves, Pedro Falcao
    Falcao, Luiz Menezes
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (06) : e744 - e750
  • [8] Impact of Antiplatelet Therapy in Heart Disease
    Renda, Giulia
    de Caterina, Raffaele
    [J]. ANTIPLATELET THERAPY IN ACS AND A-FIB, 2012, 47 : 5 - 19
  • [9] Antiplatelet therapy for ischemic heart disease
    Lange, RA
    Hillis, LD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (03): : 277 - 280
  • [10] Antiplatelet therapy for ischemic heart disease
    Steimle, AE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (20): : 2101 - 2102